Drug: |
||||
---|---|---|---|---|
Trial Name: |
A Phase IA, two-arm, multi-center, dose escalating study of LBH589 administered intravenously on two dose schedules in adult patients with advanced solid tumors & non-Hodgkin’s lymphoma. |
|||
NCT#: |
||||
Conditions: |
Advanced Solid Tumors |
|||
Status: |
Ongoing, but not recruiting |
|||
Phase: |
1 |
Start Date |
Age of Trial (yrs) |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
HDAC inhibitor |
|||
Strategy: |
Block KIT
Unblock cell death genes |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
||||
Sponsor: |
Novartis |
|||
Patient Contact: |
Donna Adkins |
|||
Contact email: |
dadkins@nvcancer.org |
|||
Contact Phone: |
(702) 822-5173 |
|||
Randomized: |
Randomized |
|||
IV or Oral: |
IV
Oral |
|||
Trial Notes: |
This trial is listed in the NVCI site but is not on the list of active trials as of 12-1-08. Checked again on 5/18/09. Still not listed at NVCI. |
Trial Links |
Trial Results |
Name |
Address |
City |
State |
Zip |
Country |
10441 W Twain Ave |
Las Vegas |
NV |
89135 |
USA |